SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Meyler's Side Effects of Drugs, 2016,

    CrossRef

  2. 2
    Luz Fonacier, David I. Bernstein, Karin Pacheco, D. Linn Holness, Joann Blessing-Moore, David Khan, David Lang, Richard Nicklas, John Oppenheimer, Jay Portnoy, Christopher Randolph, Diane Schuller, Sheldon Spector, Stephen Tilles, Dana Wallace, Contact Dermatitis: A Practice Parameter–Update 2015, The Journal of Allergy and Clinical Immunology: In Practice, 2015, 3, 3, S1

    CrossRef

  3. 3
    Yee Kiat Heng, Yen Loo Lim, Cutaneous adverse drug reactions in the elderly, Current Opinion in Allergy and Clinical Immunology, 2015, 15, 4, 300

    CrossRef

  4. 4
    Tugba Arikoglu, Gulen Aslan, Sehra Birgul Batmaz, Gulcin Eskandari, Ilter Helvaci, Semanur Kuyucu, Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests, International Journal of Clinical Pharmacy, 2015, 37, 4, 583

    CrossRef

  5. 5
    Christian Möbs, Wolfgang Pfützner, Cellular in vitro diagnosis of adverse drug reactions, Allergo Journal International, 2014, 23, 5, 164

    CrossRef

  6. You have free access to this content6
    P. Demoly, N. F. Adkinson, K. Brockow, M. Castells, A. M. Chiriac, P. A. Greenberger, D. A. Khan, D. M. Lang, H.-S. Park, W. Pichler, M. Sanchez-Borges, T. Shiohara, B. Y.-H. Thong, International Consensus on drug allergy, Allergy, 2014, 69, 4
  7. 7
    Mariana Couto, Diana Silva, Ana Ferreira, Josefina R. Cernadas, Intradermal Tests for Diagnosis of Drug Allergy are not Affected by a Topical Anesthetic Patch, Allergy, Asthma & Immunology Research, 2014, 6, 5, 458

    CrossRef

  8. 8
    Delphine Brajon, Sophie Menetre, Julie Waton, Claire Poreaux, Annick Barbaud, Non-irritant concentrations and amounts of active ingredient in drug patch tests, Contact Dermatitis, 2014, 71, 3
  9. 9
    S. Ohtoshi, Y. Kitami, H. Sueki, T. Nakada, Utility of patch testing for patients with drug eruption, Clinical and Experimental Dermatology, 2014, 39, 3
  10. 10
    Christian Möbs, Wolfgang Pfützner, Zelluläre In-vitro-Diagnostik von Arzneimittelreaktionen, Allergo Journal, 2014, 23, 5, 28

    CrossRef

  11. 11
    Y.-T. Lin, Y.-C. Chang, R.C.-Y. Hui, C.-H. Yang, H.-C. Ho, S.-I. Hung, W.-H. Chung, A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 3
  12. 12
    Bengu Gerceker Turk, Asli Gunaydin, Ilgen Ertam, Gunseli Ozturk, Adverse cutaneous drug reactions among hospitalized patients: five year surveillance, Cutaneous and Ocular Toxicology, 2013, 32, 1, 41

    CrossRef

  13. 13
    L. Klimek, C. Aderhold, A. Sperl, Allergien auf Antibiotika, HNO, 2013, 61, 5, 409

    CrossRef

  14. 14
    Scott D. Dickson, Kimberly C. Salazar, Diagnosis and Management of Immediate Hypersensitivity Reactions to Cephalosporins, Clinical Reviews in Allergy & Immunology, 2013, 45, 1, 131

    CrossRef

  15. 15
    Serria Hammami, Hanen Affes, Kamilia Ksouda, Manel Feki, Zouheir Sahnoun, Khaled Mounir Zeghal, Étude de l’allergie croisée entre les différents inhibiteurs de la pompe à protons, Thérapie, 2013, 68, 6, 361

    CrossRef

  16. 16
    M.E. Polak, G. Belgi, C. McGuire, C. Pickard, E. Healy, P.S. Friedmann, M.R. Ardern-Jones, In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions, British Journal of Dermatology, 2013, 168, 3
  17. 17
    Jussi Liippo, Kati Pummi, Ulla Hohenthal, Kaija Lammintausta, Patch testing and sensitization to multiple drugs, Contact Dermatitis, 2013, 69, 5
  18. 18
    Marcella Rita Aquino, Janelle Sher, Luz Fonacier, Patch Testing for Drugs, Dermatitis, 2013, 24, 5, 205

    CrossRef

  19. 19
    Marina Atanasković-Marković, Francesco Gaeta, Marija Gavrović-Jankulović, Tanja Čirković Veličković, Rocco Luigi Valluzzi, Antonino Romano, Diagnosing multiple drug hypersensitivity in children, Pediatric Allergy and Immunology, 2012, 23, 8
  20. 20
    You Won Choi, Drug Eruption, The Ewha Medical Journal, 2012, 35, 2, 76

    CrossRef

  21. 21
    Ayse Betul Buyuktiryaki, Handan Bezirganoglu, Umit Murat Sahiner, Suleyman Tolga Yavuz, Ayfer Tuncer, Ates Kara, Cansin Sackesen, Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl, Australasian Journal of Dermatology, 2012, 53, 4
  22. 22
    Karolyn A. Wanat, Carrie L. Kovarik, Nicole Fett, Pustular Eruption in the ICU, The American Journal of Medicine, 2012, 125, 8, 758

    CrossRef

  23. 23
    Iris S. Ale, Howard I. Maibach, Dermatotoxicology, 2012,

    CrossRef

  24. 24
    C. Ponvert, Y. Perrin, A. Bados-Albiero, M. Le Bourgeois, C. Karila, C. Delacourt, P. scheinmann, J. De Blic, Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests, Pediatric Allergy and Immunology, 2011, 22, 4
  25. 25
    Thomas Hubiche, Brigitte Milpied, Christine Cazeau, Alain Taïeb, Christine Léauté-Labrèze, Association of Immunologically Confirmed Delayed Drug Reaction and Human Herpesvirus 6 Viremia in a Pediatric Case of Drug-Induced Hypersensitivity Syndrome, Dermatology, 2011, 222, 2, 140

    CrossRef

  26. 26
    Chi Yeon Kim, Jin Gu Kim, Chee Won Oh, Fluconazole Induced Fixed Drug Eruption, Annals of Dermatology, 2011, 23, Suppl 1, S1

    CrossRef

  27. 27
    F. Lavaud, C. Mouton, C. Ponvert, Les tests cutanés dans le bilan diagnostique des réactions d’hypersensibilité peranesthésiques, Annales Françaises d'Anesthésie et de Réanimation, 2011, 30, 3, 264

    CrossRef

  28. 28
    Inseon S Choi, Eui-Ryoung Han, Seong-Wook Lim, Seong-Ryoon Lim, Ji-Na Kim, Sin-Young Park, Su-Kyoung Chae, Hye-Hyeun Lim, Young-Ae Seol, You-In Bae, Young-Ho Won, Beta-Lactam Antibiotic Sensitization and Its Relationship to Allergic Diseases in Tertiary Hospital Nurses, Allergy, Asthma and Immunology Research, 2010, 2, 2, 114

    CrossRef

  29. 29
    Iris S Ale, Howard A Maibach, Diagnostic approach in allergic and irritant contact dermatitis, Expert Review of Clinical Immunology, 2010, 6, 2, 291

    CrossRef

  30. 30
    Drug Allergy: An Updated Practice Parameter, Annals of Allergy, Asthma & Immunology, 2010, 105, 4, 259

    CrossRef

  31. 31
    Felicidade Santiago, Margarida Gonçalo, Ricardo Vieira, Sónia Coelho, Américo Figueiredo, Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS), Contact Dermatitis, 2010, 62, 1
  32. 32
    L. Barthelmes, A. Goyal, P. Sudheer, R.E. Mansel, Investigation of anaphylactic reaction after patent blue V dye injection, The Breast, 2010, 19, 6, 516

    CrossRef

  33. 33
    Peter S Friedmann, Michael Ardern-Jones, Patch testing in drug allergy, Current Opinion in Allergy and Clinical Immunology, 2010, 10, 4, 291

    CrossRef

  34. 34
    A.-C. Bursztejn, A.-C. Rat, P. Tréchot, J.-F. Cuny, J.-L. Schmutz, A. Barbaud, Résultats des tests cutanés dans l’exploration des toxidermies, Annales de Dermatologie et de Vénéréologie, 2010, 137, 11, 688

    CrossRef

  35. 35
    Hirokazu Takahashi, Yuichirou Eguchi, Haruko Uemura, Takuya Inoue, Noriko Oza, Takuya Kuwashiro, Yasunori Kawaguchi, Yasushi Ide, Toshihiko Mizuta, Iwata Ozaki, Shinichirou Soejima, Kazuma Fujimoto, The utility of natural human interferonβ in a case of chronic hepatitis C with a history of peg-interferonα2a related erythema multiforme, Kanzo, 2010, 51, 3, 112

    CrossRef

  36. 36
    David Weedon, Weedon's Skin Pathology, 2010,

    CrossRef

  37. 37
    Meyler's Side Effects of Drugs in Cancer and Immunology, 2010,

    CrossRef

  38. 38
    David Weedon, Weedon's Skin Pathology, 2010,

    CrossRef

  39. 39
    Susana Monzón, María del Mar Garcés, Apolinar Lezaun, Juan Fraj, M. Asunción Dominguez, Carlos Colás, Ambroxol-induced systemic contact dermatitis confirmed by positive patch test, Allergologia et Immunopathologia, 2009, 37, 3, 167

    CrossRef

  40. 40
    J.L. Corzo-Higueras, Drug provocation tests in children: Indications and interpretation, Allergologia et Immunopathologia, 2009, 37, 6, 321

    CrossRef

  41. 41
    A Boada, JM Carrascosa, L Leal, C Ferrándiz, Generalized cutaneous drug eruption due to strontium ranelate, Journal of the European Academy of Dermatology and Venereology, 2009, 23, 3
  42. 42
    Soon Joo Lee, Eun Mi Yang, Woo Yeon Choi, Eun Song Song, Dong Kyun Han, Young Kuk Cho, Jae Sook Ma, Late adverse reactions to iopromide (Ultravist®) diagnosed by the patch test: a case report, Korean Journal of Pediatrics, 2009, 52, 4, 499

    CrossRef

  43. 43
    E. Di Leo, E. Nettis, M. G. Priore, A. Ferrannini, A. Vacca, Maculopapular rash due to fluconazole, Clinical and Experimental Dermatology, 2009, 34, 3
  44. 44
    Robert Wessbecher, Sabine Stangl, Management of tolerance induction in patients with suspected penicillin allergy – a case study, International Journal of Dermatology, 2009, 48, 5
  45. 45
    J. Waton, P. Tréchot, C. Loss-Ayav, J.L. Schmutz, A. Barbaud, Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions, British Journal of Dermatology, 2009, 160, 4
  46. 46
    A. Barbaud, Patch-tests medicamenteux dans l’exploration des toxidermies, Annales de Dermatologie et de Vénéréologie, 2009, 136, 8-9, 635

    CrossRef

  47. 47
    Annick Barbaud, Skin Testing in Delayed Reactions to Drugs, Immunology and Allergy Clinics of North America, 2009, 29, 3, 517

    CrossRef

  48. 48
    Tatiana Tchen, Zïad Reguiaï, Fabien Vitry, Elizabeth Arnoult, Anne Grange, Grange Florent, Phillipe Bernard, Usefulness of skin testing in cutaneous drug eruptions in routine practice, Contact Dermatitis, 2009, 61, 3
  49. 49
    Neil H Shear, Brigitte Milpied, Derk P Bruynzeel, Elizabeth J Phillips, A review of drug patch testing and implications for HIV clinicians, AIDS, 2008, 22, 9, 999

    CrossRef

  50. 50
    A. C. Bursztejn, Ph. Tréchot, J. F. Cuny, J. L. Schmutz, A. Barbaud, Cutaneous adverse drug reactions during chemotherapy: consider non-antineoplastic drugs, Contact Dermatitis, 2008, 58, 6
  51. 51
    A. Padial, C. Antunez, N. Blanca-Lopez, T. D. Fernandez, J. A. Cornejo-Garcia, C. Mayorga, M. J. Torres, M. Blanca, Non-immediate reactions to β-lactams: diagnostic value of skin testing and drug provocation test, Clinical & Experimental Allergy, 2008, 38, 5
  52. 52
    Jussi Liippo, Kaija Lammintausta, Positive patch test reactions to gentamicin show sensitization to aminoglycosides from topical therapies, bone cements, and from systemic medication, Contact Dermatitis, 2008, 59, 5
  53. 53
    K. Gensch, N. Hodzic-Avdagic, M. Megahed, T. Ruzicka, A. Kuhn, Akute generalisierte exanthematische Pustulose bei nachgewiesener Typ-IV-Allergie, Der Hautarzt, 2007, 58, 3, 250

    CrossRef

  54. 54
    Annick Barbaud, Drug skin tests and systemic cutaneous adverse drug reactions: an update, Expert Review of Dermatology, 2007, 2, 4, 481

    CrossRef

  55. 55
    Mariana Cravo, Margarida Gonçalo, Américo Figueiredo, Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives, International Journal of Dermatology, 2007, 46, 7
  56. 56
    Soledad Lopez, Natalia Blanca-Lopez, Jose Antonio Cornejo-Garcia, Gabriela Canto, Maria Jose Torres, Cristobalina Mayorga, Miguel Blanca, Nonimmediate reactions to betalactams, Current Opinion in Allergy and Clinical Immunology, 2007, 7, 4, 310

    CrossRef

  57. 57
    Peter M.H. Cham, Erin M. Warshaw, Patch Testing for Evaluating Drug Reactions Due to Systemic Antibiotics, Dermatitis, 2007, 18, 2, 63

    CrossRef

  58. 58
    A. Barbaud, Prise en charge globale des toxidermies, Annales de Dermatologie et de Vénéréologie, 2007, 134, 4, 391

    CrossRef

  59. 59
    K. Scherer, L. Grize, C. Schindler, C. Surber, A. J. Bircher, Reaction pattern to histamine and codeine in a human intradermal skin test model, Clinical & Experimental Allergy, 2007, 37, 1
  60. 60
    C. Ponvert, P. Scheinmann, Réactions allergiques et pseudoallergiques aux médicaments et substances biologiques chez l’enfant, Revue Française d'Allergologie et d'Immunologie Clinique, 2007, 47, 5, 355

    CrossRef

  61. 61
    Rebeca Rodriguez-Pena, Cristina Antunez, Enrique Martin, Natalia Blanca-Lopez, Cristobalina Mayorga, Maria Jose Torres, Allergic reactions to β-lactams, Expert Opinion on Drug Safety, 2006, 5, 1, 31

    CrossRef

  62. 62
    V. Kvedariene, P. Martins, L. Rouanet, P. Demoly, Diagnosis of iodinated contrast media hypersensitivity: results of a 6-year period, Clinical & Experimental Allergy, 2006, 36, 8
  63. 63
    Jean-Claude Roujeau, Immune Mechanisms in Drug Allergy, Allergology International, 2006, 55, 1, 27

    CrossRef

  64. 64
    Andreas Beeler, Werner J Pichler, In vitrotests of T cell-mediated drug hypersensitivity, Expert Review of Clinical Immunology, 2006, 2, 6, 887

    CrossRef

  65. 65
    Yolanda Delgado-Jimenez, Silvia Perez-Gala, Maximiliano Aragüés, Javier Sanchez-Perez, Amaro Garcia-Diez, Late skin reaction to iodixanol (Visipaque®): clinical manifestations, patch test study, and histopathological evaluation, Contact Dermatitis, 2006, 55, 6
  66. 66
    D. A. Schmid, J. P.H. Depta, W. J. Pichler, T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity, Clinical & Experimental Allergy, 2006, 36, 1
  67. 67
    A. Barbaud, Toxidermies immunoallergiques chez l'immunocompétent, EMC - Dermatologie, 2006, 1, 1, 1

    CrossRef

  68. 68
    C. Ponvert, Valeurs diagnostique et prédictive des tests cutanés aux médicaments et substances biologiques, Revue Française d'Allergologie et d'Immunologie Clinique, 2006, 46, 1, 14

    CrossRef

  69. 69
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  70. 70
    A. Rozières, K. Rodet, G. Cozon, J. Bienvenu, F. Bérard, J.-F. Nicolas, Apport de la biologie dans le diagnostic de l'allergie médicamenteuse, Revue Française d'Allergologie et d'Immunologie Clinique, 2005, 45, 3, 218

    CrossRef

  71. 71
    Michael Girardi, Karynne O Duncan, Robert E Tigelaar, Suguru Imaeda, Kalman L Watsky, Jennifer M McNiff, Cross-Comparison of Patch Test and Lymphocyte Proliferation Responses in Patients With a History of Acute Generalized Exanthematous Pustulosis, The American Journal of Dermatopathology, 2005, 27, 4, 343

    CrossRef

  72. 72
    A. Romano, R.-M. Guéant-Rodriguez, M. Viola, F. Amoghly, F. Gaeta, J.-P. Nicolas, J.-L. Guéant, Diagnosing immediate reactions to cephalosporins, Clinical & Experimental Allergy, 2005, 35, 9
  73. 73
    Annick Barbaud, Drug patch testing in systemic cutaneous drug allergy, Toxicology, 2005, 209, 2, 209

    CrossRef

  74. 74
    Ronni Wolf, Edith Orion, Batsheva Marcos, Hagit Matz, Life-threatening acute adverse cutaneous drug reactions, Clinics in Dermatology, 2005, 23, 2, 171

    CrossRef

  75. 75
    J. Waton, P. Trechot, J.F. Cuny, J.L. Schmutz, A. Barbaud, P13 - Valeur prédictive négative des tests cutanés dans l’exploration des toxidermies, Annales de Dermatologie et de Vénéréologie, 2005, 132, 79

    CrossRef

  76. 76
    E. Frouin, B. Roth, A. Grange, F. Grange, M.-C. Tortel, J.-C. Guillaume, Syndrome d’hypersensibilité à la fluindione (Préviscan®). Positivité des tests épicutanés, Annales de Dermatologie et de Vénéréologie, 2005, 132, 12, 1000

    CrossRef

  77. 77
    K. Lammintausta, O. Kortekangas-Savolainen, The usefulness of skin tests to prove drug hypersensitivity, British Journal of Dermatology, 2005, 152, 5
  78. 78
    C. Jaeger, U. Jappe, Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test, Contact Dermatitis, 2005, 52, 1
  79. 79
    A. Romano, M. Blanca, M. J. Torres, A. Bircher, W. Aberer, K. Brockow, W. J. Pichler, P. Demoly, Diagnosis of nonimmediate reactions to β-lactam antibiotics, Allergy, 2004, 59, 11
  80. 80
    M.A. Padial, J. Alvarez-Ferreira, B. Tapia, R. Blanco, C. Mañas, M. Blanca, T. Bellón, Acute generalized exanthematous pustulosis associated with pseudoephedrine, British Journal of Dermatology, 2004, 150, 1
  81. 81
    A Altaykan, G Boztepe, G Erkin, Ö Özkaya, E Özden, Acute generalized exanthematous pustulosis induced by bleomycin and confirmed by patch testing, Journal of Dermatological Treatment, 2004, 15, 4, 231

    CrossRef

  82. 82
    A. Barbaud, P. Trechot, F. Weber-Muller, G. Ulrich, N. Commun, J. L. Schmutz, Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins, Contact Dermatitis, 2004, 50, 1
  83. 83
    C Ponvert, M Le Bourgeois, C Karila, J de Blic, P Scheinmann, L'allergie aux bêtalactamines chez l'enfant : diagnostic des réactions d'hypersensibilité non-immédiate par les tests cutanés (intradermoréactions et patch-tests) et les tests de réintroduction par voie orale, Revue Française d'Allergologie et d'Immunologie Clinique, 2004, 44, 4, 379

    CrossRef

  84. 84
    M.-J. Torres, E. Sánchez-Sabaté, J. Álvarez, C. Mayorga, J. Fernández, A. Padial, J.-A. Cornejo-García, T. Bellón, M. Blanca, Skin test evaluation in nonimmediate allergic reactions to penicillins, Allergy, 2004, 59, 2
  85. 85
    S. Benahmed, C. Scaramuzza, D. Messaad, H. Sahla, P. Demoly, The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial, Allergy, 2004, 59, 10
  86. 86
    A. Barbaud, Toxicodermias inmunoalérgicas en pacientes inmunocompetentes, EMC - Dermatología, 2004, 38, 3, 1

    CrossRef

  87. 87
    A Barbaud, Toxidermies immunoallergiques chez l’immunocompétent, EMC - Dermatologie-Cosmétologie, 2004, 1, 2, 75

    CrossRef

  88. 88
    Claude Ponvert, Allergic and pseudoallergic reactions to betalactam antibiotics in children, Revue Française d'Allergologie et d'Immunologie Clinique, 2003, 43, 4, 216

    CrossRef

  89. 89
    Claude Ponvert, Pierre Scheinmann, Antibiotic allergy and pseudo-allergy in child, Revue Française d'Allergologie et d'Immunologie Clinique, 2003, 43, 6, 385

    CrossRef

  90. 90
    Esther Kim, Howard Maibach, Changing paradigms in dermatology: science and art of diagnostic patch and contact urticaria testing, Clinics in Dermatology, 2003, 21, 5, 346

    CrossRef

  91. 91
    Maria Valois, Elizabeth J. Phillips, Neil H. Shear, Sandra R. Knowles, Clindamycin-associated acute generalized exanthematous pustulosis, Contact Dermatitis, 2003, 48, 3
  92. 92
    Stéphanie d'Arpino, Valérie Corbrion-Archer, Jean-Paul Marty, Laurent Lantieri, Claire-Marie Vincent, Alain Astier, Muriel Paul, Influence of vehicles on the in vitro percutaneous absorption of piroxicam to optimise the formulation of patch tests in dermatology, Drug Development Research, 2003, 58, 3
  93. 93
    C. Cholez, P. Trechot, J.-L. Schmutz, G. Faure, M.-C. Bene, A. Barbaud, Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross reactions between calcium channel blockers, Allergy, 2003, 58, 11
  94. 94
    P. S. Friedmann, M.-S. Lee, A. C. Friedmann, R. St C. Barnetson, Mechanisms in cutaneous drug hypersensitivity reactions, Clinical & Experimental Allergy, 2003, 33, 7
  95. 95
    N. Freymond, A. Catelain, F. Cousin, J. F. Nicolas, Skin delayed-type hypersensitivity to josamycin, Allergy, 2003, 58, 12
  96. 96
    A Barbaud, Usefulness of drug patch testing in cutaneous drug allergy: what is new?, Revue Française d'Allergologie et d'Immunologie Clinique, 2003, 43, 4, 222

    CrossRef

  97. 97
    C Galvão, Rfj Criado, Pr Criado, Nys Valente, Jf De Mello, Mfm Fernandes, Acute generalized exanthematous pustulosis induced by ingestion of bamifylline, Journal of the European Academy of Dermatology and Venereology, 2002, 16, 6
  98. 98
    K. Lammintausta, R. Tokola, K. Kalimo, Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure, British Journal of Dermatology, 2002, 146, 4
  99. 99
    B. Sachs, S. Erdmann, J. Malte Baron, M. Neis, T. Al Masaoudi, H. F. Merk, Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization, Clinical & Experimental Allergy, 2002, 32, 5
  100. 100
    P. Demoly, J. Bousquet, Drug allergy diagnosis work up, Allergy, 2002, 57,
  101. 101
    Vandana Kudva-Patel, Erik White, Ravi Karnani, Margaret H. Collins, Amal H. Assa'ad, Drug reaction to ceftriaxone in a child with X-linked agammaglobulinemia, Journal of Allergy and Clinical Immunology, 2002, 109, 5, 888

    CrossRef

  102. 102
    K. Brockow, A. Romano, M. Blanca, J. Ring, W. Pichler, P. Demoly, General considerations for skin test procedures in the diagnosis of drug hypersensitivity, Allergy, 2002, 57, 1
  103. 103
    K. Brockow, A. Romano, M. Blanca, J. Ring, W. Pichler, P. Demoly, General considerations for skin test procedures in the diagnosis of drug hypersensitivity, Allergy, 2002, 57, 1, 45

    CrossRef

  104. 104
    A. Romano, M. J. Torres, F. Namour, C. Mayorga, M. C. Artesani, A. Venuti, J. L. Guéant, M. Blanca, Immediate hypersensitivity to cephalosporins, Allergy, 2002, 57,
  105. 105
    S. Lateo, M.J. Boffa, Localized toxic pustuloderma associated with nimesulide therapy confirmed by patch testing, British Journal of Dermatology, 2002, 147, 3
  106. 106
    W. Pichler, N. Yawalkar, S. Schmid, A. Helbling, Pathogenesis of drug-induced exanthems, Allergy, 2002, 57, 10
  107. 107
    H. Assier-Bonnet, M. Viguier, L. Dubertret, J. Revuz, J. C. Roujeau, Severe adverse drug reactions due to pseudoephedrine from over-the-counter medications, Contact Dermatitis, 2002, 47, 3
  108. 108
    M. Blanca, C. Mayorga, M. J. Torres, R. Warrington, A. Romano, P. Demoly, F. Silviu-Dan, M. Moya, J. Fernandez, C. Juárez, Side-chain-specific reactions to betalactams: 14 years later, Clinical & Experimental Allergy, 2002, 32, 2
  109. 109
    M.R. Wilkins, What do we want from proteomics in the detection and avoidance of adverse drug reactions, Toxicology Letters, 2002, 127, 1-3, 245

    CrossRef

  110. 110
    C.J Le Coz, À propos du questionnaire européen pour le diagnostic des allergies médicamenteuses, Revue Française d'Allergologie et d'Immunologie Clinique, 2001, 41, 2, 221

    CrossRef

  111. 111
    Antonino Romano, Maria J. Torres, Marina Di Fonso, Laura Leyva, Maria Andriolo, Rosa Pettinato, Miguel Blanca, Delayed hypersensitivity to cefazolin: report on a case involving lymphocyte transformation studies with different cephalosporins, Annals of Allergy, Asthma & Immunology, 2001, 87, 3, 238

    CrossRef

  112. 112
    C Ponvert, F Chedevergne, M Le Bourgeois, J de Blic, J Paupe, P Scheinmann, Diagnostic des réactions dˈhypersensibilité non immédiate aux bêtalactamines chez lˈenfant par les tests cutanés à lecture semi-retardée et retardée et par les tests de réintroduction, Revue Française d'Allergologie et d'Immunologie Clinique, 2001, 41, 6, 544

    CrossRef

  113. 113
    Genevieve Choquet-Kastylevsky, Thierry Vial, Jacques Descotes, Drug allergy diagnosis in humans: possibilities and pitfalls, Toxicology, 2001, 158, 1-2, 1

    CrossRef

  114. 114
    Debbie Shipley, Anthony D. Ormerod, Drug-Induced Urticaria, American Journal of Clinical Dermatology, 2001, 2, 3, 151

    CrossRef

  115. 115
    Annick Barbaud, Margarida Gonçalo, Derk Bruynzeel, Andreas Bircher, Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactions, Contact Dermatitis, 2001, 45, 6
  116. 116
    Jean Revuz, NEW ADVANCES IN SEVERE ADVERSE DRUG RESCTIONS, Dermatologic Clinics, 2001, 19, 4, 697

    CrossRef

  117. 117
    A. Barbaud, P. Trechot, S. Reichert-Penetrat, N. Commun, J. L. Schmutz, Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions, Contact Dermatitis, 2001, 45, 5
  118. 118
    Roland M. Strauss, Steven T. Green, David J. Gawkrodger, Rifampicin allergy confirmed by an intradermal test, but with a negative patch test, Contact Dermatitis, 2001, 45, 2
  119. 119
    Markus Britschgi, Urs C. Steiner, Simone Schmid, Jan P.H. Depta, Gabriela Senti, Andreas Bircher, Christoph Burkhart, Nikhil Yawalkar, Werner J. Pichler, T-cell involvement in drug-induced acute generalized exanthematous pustulosis, Journal of Clinical Investigation, 2001, 107, 11, 1433

    CrossRef

  120. 120
    A. Barbaud, P. Trechot, S. Reichert-Penetrat, F. Granel, J. L. Schmutz, The usefulness of patch testing on the previously most severely affected site in a cutaneous adverse drug reaction to tetrazepam, Contact Dermatitis, 2001, 44, 4
  121. 121
    Juan Antonio Ratón, José Luis Díaz, Utilidad de las pruebas epicutáneas en el diagnóstico de las toxicodermias, Piel, 2001, 16, 2, 57

    CrossRef

  122. 122
    R Apaydin, Bilen, Ş Dökmeci, D Bayramgürler, G Yildirim, Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital, Journal of the European Academy of Dermatology and Venereology, 2000, 14, 6
  123. 123
    Antonino Romano, Recognising Antibacterial Hypersensitivity In Children, Pediatric Drugs, 2000, 2, 2, 101

    CrossRef

  124. 124
    Antonino Romano, Recognising Antibacterial Hypersensitivity In Children, Paediatric Drugs, 2000, 2, 2, 101

    CrossRef

  125. 125
    A Sparsa, V Loustaud-Ratti, M Mousset-Hovaere, P De Vencay, V Le Brun, E Liozon, P Soria, C Bédane, M.L Bouyssou-Gauthier, S Boulinguez, J.M Bonnetblanc, E Vidal, Syndrome d’hypersensibilité médicamenteuse en pratique interniste : pièges diagnostique et thérapeutique.Huit observations, La Revue de Médecine Interne, 2000, 21, 12, 1052

    CrossRef

  126. 126
    Nikhil Yawalkar, Yvonne Hari, Karin Frutig, Fabienne Egli, Thomas Wendland, Lasse R. Braathen, Werner J. Pichler, T Cells Isolated from Positive Epicutaneous Test Reactions to Amoxicillin and Ceftriaxone are Drug Specific and Cytotoxic, Journal of Investigative Dermatology, 2000, 115, 4, 647

    CrossRef

  127. 127
    Andrea Panhans-Gross, Helmut Gall, Ralf-Uwe Peter, Baboon syndrome after oral penicillin, Contact Dermatitis, 1999, 41, 6
  128. 128
    Evidence-Based Commentary, Annals of Allergy, Asthma & Immunology, 1999, 83, 6, 677

    CrossRef

  129. 129
    A. Barbaud, S. Reichert-Penetrat, F. Granel, M.-N. Kolopp-Sarda, J.-L. Schmutz, Is terbinafine responsible for eliciting positive patch tests performed with Lamisil® tablets?, Contact Dermatitis, 1999, 41, 2
  130. 130
    A. Barbaud, Les allergies médicamenteuses de contact. Actualités et conseils vis-à-vis des prescriptions de médicaments administrés par voie générale, Revue Française d'Allergologie et d'Immunologie Clinique, 1999, 39, 4, 301

    CrossRef

  131. 131
    C. Ponvert, M. Le Bourgeois, P. Scheinmann, J. Paupe, Les réactions allergiques aux médicaments anti-infectieux courants, Revue Française d'Allergologie et d'Immunologie Clinique, 1999, 39, 6, 455

    CrossRef

  132. 132
    C. Mayence, A. Dompmartin, L. Verneuil, M. Michel, D. Leroy, Value of patch tests in pristinamycin-induced drug eruptions, Contact Dermatitis, 1999, 40, 3
  133. 133
    Barbaud, TRÉchot, Reichert-PÉNÉtrat, Weber, Schmutz, Allergic mechanisms and urticaria/angioedema after hepatitis B immunization, British Journal of Dermatology, 1998, 139, 5
    Direct Link:
  134. 134
    A. Barbaud, P. Tréchot, A. Aublet-Cuvelier, S. Reichert-Penetrat, J.-L. Schmutz, Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions, Contact Dermatitis, 1998, 39, 5
  135. 135
    Vincent A DeLeo, Skin testing in systemic cutaneous drug reactions, The Lancet, 1998, 352, 9139, 1488

    CrossRef

  136. 136
    A. Barbaud, Tests épicutanés médicamenteux dans les toxidermies, Revue Française d'Allergologie et d'Immunologie Clinique, 1998, 38, 4, 374

    CrossRef